The DualDur test is a unique Hungarian innovation capable of making visible the bacterium Borrelia, which causes Lyme disease.

After a simple blood draw, the test can detect the pathogen both in the early stage of infection (4–6 days after the tick bite) and in later stages as well.

It is the result of forty years of scientific work, supported by tens of thousands of completed tests and Europe’s largest Lyme diagnostics study. The European Parliament’s resolution on Lyme disease recommends DualDur and similar innovative approaches for the early detection of the illness. DualDur is the only diagnostic method for detecting Lyme disease that has been validated in public, pre-designed studies in Europe, and is performed in a Hungarian, accredited laboratory.

Since the DualDur test directly detects the pathogen itself, it not only provides tangible evidence of the infection, but also offers guidance to physicians regarding the appropriate therapy.

DualDur is the first generally applicable laboratory test capable of concentrating enough pathogens from a blood sample to make them visible under a microscope during the course of the disease — even in stages where chronic symptoms are present.

The system, with the help of artificial intelligence, is able to distinguish between cases that do not yet show symptoms and those that experts would likely already recommend for treatment.

We recommend performing the test upon the advice of a specialist; without the presence of symptoms, it should only be used to assess the success of treatment.

Further information about the DualDur test can be found here.

Further information about the blood draw can be found here.

You may also register for the examination by filling out the form below, after which our colleagues will contact you.

The images show Borrelia burgdorferi bacteria labeled with an immunofluorescent reagent, photographed by DD-Lab Ltd.